Effect of whitening dentifrices: a double-blind randomized controlled trial
AUTOR(ES)
PINTADO-PALOMINO, Karen, VASCONCELOS, Cecília Vilela Matias, SILVA, Roberto Juns da, FRESSATTI, Andre Luiz de Macedo, MOTTA, Bianka Jurca Gonçalves da, PIRES-DE-SOUZA, Fernanda de Carvalho Panzeri, TIRAPELLI, Camila
FONTE
Braz. oral res.
DATA DE PUBLICAÇÃO
10/10/2016
RESUMO
Abstract The aim of this clinical study was to evaluate tooth color changes (ΔE) and tooth sensitivity (TS) associated with whitening dentifrices. Sixty participants were selected according to inclusion and exclusion criteria and then allocated to three groups (n = 20): Colgate Luminous White (G1), Close Up White Now (G2) and Sorriso dentifrice (G3-control). The participants were instructed to use only the provided dentifrice and toothbrush in standardized oral hygiene procedures for 4 weeks. ΔE was assessed by spectrophotometry (CIELab System) whereas TS was determined by a visual analog scale at baseline and weekly using four assessment points. The data were analyzed by two-way ANOVA and Tukey’s post-hoc test and Friedman test (α = 0.05). ΔE (baseline-assessment point 4) showed no significant difference (p>0.05) across the groups: G1 (ΔE = 5.1), G2 (ΔE = 6.8), and G3 (ΔE = 4.4). Δb (baseline-assessment point 4) was significantly different (p < 0.05) in G2 (3.8) when compared to G1 (-0.2) and G3 (0.3). There was no significant difference (p > 0.05) in TS at baseline. Both the control and whitening dentifrices caused similar tooth color changes (ΔE). There was no significant TS during the study period.
Documentos Relacionados
- Penotrane in blepharitis. A double-blind controlled trial.
- Azathioprine: a controlled, double-blind trial in rheumatoid arthritis.
- Azathioprine in active chronic iridocyclitis. A double-blind controlled trial.
- Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]
- Letter: Griseofulvin therapy in Herpes progenitalis (a double-blind controlled trial).